Stratifiers for oxaliplatin outcome in colorectal cancer
<p>Colorectal cancer (CRC) is the second most common cancer in terms of mortality in the world. Oxaliplatin is the one of the most common approved adjuvant chemotherapeutic drugs for advanced stage II and stage III. Despite the improvement in outcome, a high percentage of cases show lack of re...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2021
|
| Subjects: |